chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: I had a series of migraines after dose 1 of the vaccine; This is a spontaneous report from a contactable consumer. A 69-years-old female patient (not pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9261) via an unspecified route of administration, administered in left arm on 30Jan2021 at 10:15 at single dose for covid-19 immunization.Medical history included covid-19 from Jul2020 since having covid in july. The patient's concomitant medications were not reported. No Known allergies. No other vaccine in four weeks. No other medications in two weeks. She had covid prior vaccination. No covid tested post vaccination. On 04Feb2021 at 08:00 am, she had a series of migraines after dose 1 of the vaccine. Since having Covid in July she had more migraines than normal. She used to get 4 or 5 a year. She have probably had 10 to 12 since July. The event assessed as non-serious. No treatment was received. The outcome of event was not recovered.  No follow up attempts are possible. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia
Clinical narrative: moderate memory loss after 2nd injection; This is a spontaneous report from a contactable consumer (patient). The 69-year-old non-pregnant female patient received second dose of PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Batch/ Lot Number and expiry date were not provided), via an unspecified route of administration, in the left arm, on 17Feb2021 (at the age of 69-year-old) as a single dose for covid-19 immunisation. The patient did not have any allergies to medications, food or other products. Patient's medical history and concomitan medications were not reported. Patient previously received first dose of covid vaccine on 27/01/2021 and experienced mild, short-term memory loss. Patient did not have covid prior vaccination. Patient was not tested covid post vaccination. Patient did not receive any other vaccine in four weeks. Patient did not receive other medications in two weeks. On 27Jan2021 at 10:30, patient experienced moderate memory loss after 2nd injection. Patient visited emergency room due to event. As reported, treatment received was unknown. The outcome of event was not resolved.  Information of lot/batch number has been requested.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore left arm; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female received first dose of BNT162B2 ((PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number EN6198) via unspecified route of administration in left arm on 27Feb2021 at 01:15 PM as single dose for COVID-19 immunisation. Medical history included glaucoma, diffuse large B-cell lymphoma (DLBCL), thyroid nodules. Concomitant medication included levothyroxine, vitamin D Nos [VITAMIN D], tocopherol (VITAMIN E), curcumin, acetylsalicylic acid (ASA), fenofibrate (NORTRICOL) (medications in two weeks). No other vaccine in four weeks. On 27Feb2021 at 03:00 PM, patient experienced sore left arm. No covid prior vaccination, Patient has not tested COVID post vaccination. The case was considered as nonserious. The outcome of event was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea; This is a spontaneous report from a contactable consumer (patient's wife) via Pfizer-sponsored program. A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number unknown, Expiration date unknown), via an unspecified route of administration on an unknown date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 21Feb2021 (today), the patient had experienced diarrhea upon waking up. Second dose was due 21Feb2021 (today) and reporter was worried about having patient take the second dose. The outcome of the event was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood test, Decreased appetite, Fatigue, Headache
Clinical narrative: lost her appetite; Slight fever; tiredness; headaches; Nausea; Weakness; This is a spontaneous report from a contactable consumer(patient). A 73-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EI9269), first dose via an unspecified route of administration, administered in left arm on 17Feb2021 as SINGLE DOSE for covid-19 immunization. Patient was 73 years old at the time of vaccination. The patient's medical history and concomitant medications were not reported. On 17feb2021, Wednesday the patient went to work after getting the vaccine and about 2 or 3 in the afternoon, she started having headaches, and nausea that came on slowly. She also experienced tiredness and weakness. She had a slight fever also, but she took Tylenol and that went away. Next day on 18Feb2021 the patient lost her appetite. She was still experiencing tiredness, weakness and headaches as well as the loss of appetite and nausea. She was wondering if she should expect the same side effects from the second dose, as she was scheduled for it on 10Mar2021, and she was scared she might get the same side effects, because she still had not been able to go back to work yet. Her nausea had improved a very little, but when she moves around it persists again, but when she rests is slows down. She confirmed that she had no other vaccines on the same day as her COVID vaccine. The patient underwent lab tests and procedures which included blood test: unknown: she has not received the results yet. She had not taken any medication at all, because all the medicines she was taking, she did not take them because she was worried they would interfere with the vaccine. Stated that when she gets the flu, which is very seldom, it is months before she gets better and states that the symptoms she was experiencing now, were the same thing she experiences when she has the flu. Therapeutic measures were taken as a result of slight fever. The outcome of fever was reported as unknown and other events was recovering.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: lost her appetite; Slight fever; tiredness; headaches; Nausea; Weakness; This is a spontaneous report from a contactable consumer(patient). A 73-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EI9269), first dose via an unspecified route of administration, administered in left arm on 17Feb2021 as SINGLE DOSE for covid-19 immunization. Patient was 73 years old at the time of vaccination. The patient's medical history and concomitant medications were not reported. On 17feb2021, Wednesday the patient went to work after getting the vaccine and about 2 or 3 in the afternoon, she started having headaches, and nausea that came on slowly. She also experienced tiredness and weakness. She had a slight fever also, but she took Tylenol and that went away. Next day on 18Feb2021 the patient lost her appetite. She was still experiencing tiredness, weakness and headaches as well as the loss of appetite and nausea. She was wondering if she should expect the same side effects from the second dose, as she was scheduled for it on 10Mar2021, and she was scared she might get the same side effects, because she still had not been able to go back to work yet. Her nausea had improved a very little, but when she moves around it persists again, but when she rests is slows down. She confirmed that she had no other vaccines on the same day as her COVID vaccine. The patient underwent lab tests and procedures which included blood test: unknown: she has not received the results yet. She had not taken any medication at all, because all the medicines she was taking, she did not take them because she was worried they would interfere with the vaccine. Stated that when she gets the flu, which is very seldom, it is months before she gets better and states that the symptoms she was experiencing now, were the same thing she experiences when she has the flu. Therapeutic measures were taken as a result of slight fever. The outcome of fever was reported as unknown and other events was recovering.
Sex: M
Vaccine: COVID19
Symptoms: Cluster headache, Feeling abnormal, Taste disorder, Tinnitus
Clinical narrative: Cluster headaches that was in remission for the last three years have returned with a vengeance; Bad taste in my mouth; Head feels foggy; ringing in my right ear; This is a spontaneous report from a contactable consumer (Patient). A male patient (age: 67 unit: not given) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL8982), via an unspecified route of administration in right arm on 30Jan2021 at 03:15 PM as single dose for COVID-19 immunization. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL3249) via unspecified route of administration in right arm on 09Jan2021 at 03:15 PM as single dose for COVID-19 immunization. Medical history included cluster headaches. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not have any known allergies. Concomitant medications included levothyroxine sodium (SYNTHROID) and verapamil hydrochloride. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Feb2021, patient head feels foggy, developed ringing in my right ear. Cluster headaches that was in remission for the last three years have returned with a vengeance, bad taste in my mouth. No treatment was received. The events resulted in doctor or other healthcare professional office/clinic visit. The outcome of the events was not recovered.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Little tired; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 09Feb2021 18:45 (Lot Number: EN6201) at the age of 71 years old as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Facility type vaccine was Pharmacy or Drug Store. No other vaccine in four weeks. The patient experienced little tired on 11Feb2021 12:00. No treatment received for the event. No COVID prior vaccination and no COVID tested post vaccination. The outcome of the event was recovered on an unspecified date in Feb2021.  No follow-up attempts are possible. No further information is expected.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: she woke up and her right leg from her knee to her hip was beet red and itching; her left arm was itching; This is a spontaneous report from a contactable consumer (Patient). A 84-year-old female patient received first dose of BNT162B2 (Covid 19 Vaccine, Formulation: Solution for injection, Batch/Lot no: EL9264, expiry date 30May2021) via an unspecified route of administration on 18Feb2021 as single dose for COVID-19 immunization. The patient medical history included Back pain (she takes a pain pill for a pain in her back every once in a while, and lung cancer but she is in remission right now. It is Percocet and it is the lowest dose of Percocet). The patient concomitant medications were not reported. On 22Feb2021, the patient experienced the itching and redness early Monday morning. she woke up and her right leg from her knee to her hip was beet red and itching and her left arm was itching. She is not on any medication she takes a pain pill for a pain in her back every once in a while. It is a Percocet, and it is the lowest dose of Percocet. She does not take it every day. She is not on anything else except a blood pressure pill. The outcome of the events she woke up and her right leg from her knee to her hip was beet red and itching and her left arm was itching were reported as unknown.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Pain in extremity
Clinical narrative: I can't sleep at night; arm hurts so it has settled in joints, shoulder, and up neck to down to elbow; This is a spontaneous report from a contactable consumer. A 67-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration, in right arm on 13Feb2021 as single dose for COVID-19 immun-ization. Patient's medical history and patient's concomitant medications were not reported. On 14Feb2021, Patient reported, I can't sleep at night and arm hurts so it has settled in joints, shoulder, and up neck to down to elbow. Patient wanted to know that how long this will last. Treatment for the events was Tylenol. LOT#: Patient stated that Pfizer GN5318, it looked like. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash; This is a spontaneous report from a contactable consumer (patient). A 69-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot no. EN6200; Expiration date: unknown) via an unspecified route of administration on 13-FEB-2021 at single dose for COVID -19 immunisation. The patient medical history and concomitant medications were not reported. patient experienced a rash three days after received first dose. patient received treatment with Hydrocortisone cream and it has started to go away and Benadryl. it was reported that second dose scheduled on 6Mar2021. the outcome of event was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Swelling face, Tenderness
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 70-year-old female consumer received unspecified dose number of BNT162B2 (solution for injection; Batch/Lot Number: EN6203) via an unspecified route of administration on 22Feb2021 as single dose for COVID-19 immunization. Medical history included hypertension, diabetes mellitus and thyroid. Concomitant medications included metoprolol, lisinopril, glipizide, metformin. On 22Feb2021, the patient experienced swelling in my face and arm was extremely sore and tender. No treatment received for the adverse events. The outcome of the event arm is extremely sore and tender was recovered and swelling in face was not recovered.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Insomnia, Magnetic resonance imaging, Memory impairment, Muscle disorder
Clinical narrative: Could not sleep; Effected upper part of my body, my arms, my neck, my shoulders, It's been very severe/ /severe muscle condition; I had tiny bit of shingles on my side; I did not have memory of anything that happened/Do not remember all of it, I was out of my mind; This is a spontaneous report from a contactable consumer (patient). An 85-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN5318, Expiration Date: unknown), dose 2 via an unspecified route of administration on 17Feb2021 as single dose for COVID-19 immunization. Medical history included blood pressure and cholesterol. Concomitant medications included hydrochlorothiazide taken for blood pressure and rosuvastatin taken for cholesterol. On 20Feb2021, the patient experienced could not sleep. In Feb2021, the patient experienced effected upper part of body, arms, neck, shoulders, it's been very severe/severe muscle condition, had tiny bit of shingles on my side, did not have memory of anything that happened/do not remember all of it, was out of my mind. The patient reported that she had some very severe muscle condition. She could not sleep. It was horrible. The patient understood that they put it in the muscle so that is why she was feeling that. It's been very severe, she was ok now and she think it is going to be better now. She have been taking treatment Tylenol 500 mg, two of them every 6 hours and the doctor gave a medication for tiny bit of shingles on my side to keep it from growing any further. The patient did not remember all of it, she was out of her mind. They took her to the hospital and then the patient underwent MRI to see if her brain was okay and they come up with a conclusion that is what it was and she did not have memory of anything that happened. The outcome of the events was recovering.   No follow-up attempts are possible; No information is required.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pain
Clinical narrative: raised bumps on torso from neck to butt, about 10 of them, when run finger over them they sting for a few seconds; also dizzy last night; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 46-years-old non-pregnant female patient received BNT162B2 (BNT162B2) via an unspecified route of administration, in left arm on 13Feb2021 at 17:15  as single dose for COVID-19 immunization at the age 46 years. Medical history included hypothyroidism and osteoarthritis. Concomitant medication(s) included Synthroid. No known allergies were reported. Patient did not receive any other vaccines in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient was not tested for COVID-19. On 20Feb2021, patient experienced raised bumps on torso from neck to butt, about 10 of them, when run finger over them they stung for a few seconds, also dizzy last night and investigated bed bugs or mites but haven't found evidence of them. No treatment was received for the events. Outcome of the events was not recovered.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness in my arm; This is a spontaneous report from a contactable consumer (patient). The 73-year-old female patient received BNT162B2 (COMIRNATY, solution for injection) (Batch/Lot Number: EN6200) on 18Feb2021 (at the age of 73-years-old) via unspecified route of administration as a single dose for COVID-19 immunization. The medical history included Rheumatoid arthritis (since 1999). Patient had rheumatoid arthritis, she was wondering if it was okay for her to take Tylenol after, well she had shot like 5 days ago, for arthritis pain. The concomitant medication included Methotrexate (Four 2.5 mg, Weekly) for Rheumatoid arthritis, Folic acid (1mg) Prescribed to 1 mg to counteracts the side effects of Methotrexate that was also prescribed, Vitamin D3 (2000 units), calcium citrate and Turmeric(It was just supposed to help arthritis so she took that over the counter. It was not prescribed). Patient reported soreness in arm. Patient didn't have any pain other than little bit of soreness in arm after the shot. This was just an ongoing thing. Patient further explained pain in her knees from ski. When she did ski she wanted to able to take Tylenol before she went skiing but patient didn't wanted to affect her have a Covid shot would work. Patient reported action(s) taken with drug was unknown. Patient did not receive any treatment. The outcome of the event was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Dental caries
Clinical narrative: Dental cavity; This is a spontaneous report received from a contactable consumer (reporting on herself). A 76-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot Number: EN6200 and Expiration Date was not reported), via an unspecified route of administration in Arm Right on 18Feb2021 12:00 as single dose for COVID-19 immunization. Medical history included atrial fibrillation, hypothyroidism, blood pressure ab-normal, hypoacusis all from an unknown date and unknown if ongoing. Concomitant medication(s) included levothyroxine (LEVOTHYROXINE) taken for hypothyroidism from an unspecified start date and ongoing (has been taking for at least 2 years); apixaban (ELIQUIS) taken for atrial fibrillation from 2018 and ongoing; diltiazem hydrochloride (DILTIAZEM CD) taken for blood pressure abnormal from 2016 and ongoing; metoprolol tartrate (METOPROLOL TARTRATE) taken for blood pres-sure abnormal from an unspecified start date and ongoing (has been taking for a couple of years); colecalciferol (VITAMIN D3) taken for an unspecified indication from an unspecified start date and ongoing (has been taking since at least 2016); cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]) taken for an unspecified indication from 2016 and ongoing (She does not know why she takes this. She states she was low on something). Historical vaccine includes Flu shot. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that on 18Feb2021 first dose of the BNT162B2. She did not have any problems after getting the vaccine. She goes back on 11Mar2021 for the second dose. Patient mentioned that she was hard of hearing. Confirms this has been going on for a long time. She diagnosed with a cavity and has an appointment to have it filled the day prior to receiving the second dose. She has a dentist appointment on 10Mar2021 to have a cavity filled. Asking will this be a problem. She will probably have to have Novacaine but she does not know. Yesterday she went for a 6 month check-up and was found to have a cavity. She was scheduled for an appointment to have the cavity filled. Patient was asking should she cancel the appointment. She had a flu shot in Sep2020. She has not had any other vaccines. The outcome of the event was unknown.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles - right gluteal region -  S2 dermatome - 7 days after dose 2; This is a spontaneous report from a contactable physician (the patient). A 46-years-old non-pregnant female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: El9266, Expiration date: Unknown), via intramuscular, administered in right arm on 17Feb2021 08:00 (at the age of 46-years-old) as a single dose for COVID-19 immunization. Patient previously received first dose of bnt162b2 on 22Jan2021 for covid-19 immunization. The patient had known allergies with Latex, adhesive, perfume, fragrance, pollen. The patient was not pregnant at the time of vaccination. The patient had no other vaccine in four weeks and no other medication within 2 weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient medical history and concomitant medications were not reported. On 23Feb2021 08:00, the patient experienced shingles - right gluteal region - S2 dermatome - 7 days after dose 2. The patient was not given treatment. Outcome of event was not recovered.  No follow up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain of skin
Clinical narrative: This is a spontaneous report from a contactable male (husband). Caller and his wife of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), via an unspecified route of administration on 18Feb2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient experienced soreness in the skin and reported that the soreness was experienced in 6 years' time. The patient wanted to know if she can take Tylenol or Ibuprofen for the soreness of skin. The outcome of event was unknown. Information on the lot/batch number has been requested.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Swelling in the lower legs and feet; This is a spontaneous report from a contactable consumer (Patient). A 82-year-old (non-pregnant) female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown), via an unspecified route of administration in left arm on 22Feb2021 at 10:00 AM as single dose for COVID-19 immunization. Patient had historical vaccine (at 82-year-old) BNT162B2, first dose in left arm on 01Feb2021 11:00 AM for COVID-19 immunization. There was no other vaccine in four weeks. Patient medical history included glaucoma, high blood pressure, pacemaker and known allergies from Sulfa. The patient took concomitant medications (Other medications in two weeks). On 01Mar2021 at 08:00 AM, the patient experienced swelling in the lower legs and feet. There was no COVID prior vaccination and not tested for COVID post vaccination. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster, Varicella
Clinical narrative: shingles; chicken pox; This is a spontaneous report from a Pfizer sponsored program. A contactable 71-year-old female consumer(patient) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Expiration date: Unknown), via an unspecified route of administration on unspecified date as single dose for COVID-19 immunization. Patient medical history and concomitant medications were no reported. Patient had a condition called shingles chicken pox and Patient currently on a medication of Valtrex and was about to finish taking it on Wednesday. The outcome of event was unknown.   Information on the Lot/batch number has been requested.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; chicken pox; This is a spontaneous report from a Pfizer sponsored program. A contactable 71-year-old female consumer(patient) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Expiration date: Unknown), via an unspecified route of administration on unspecified date as single dose for COVID-19 immunization. Patient medical history and concomitant medications were no reported. Patient had a condition called shingles chicken pox and Patient currently on a medication of Valtrex and was about to finish taking it on Wednesday. The outcome of event was unknown.   Information on the Lot/batch number has been requested.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: itching at injection site; swelling at injection site; injection site warm to touch; This is a spontaneous report from a contactable consumer (patient). A 65-year-old male patient received bnt162b2 (BNT162B2 Formulation: Solution for injection, Batch/Lot number: EN6198, Expiry Date: 30Jun2021), on left arm at the age of 65, dose 2 via an unspecified route of administration on 20Feb2021 as single dose, dose 1 (Lot EL9266, Expiry: 31May2021) via an unspecified route of administration on 30Jan2021 as single dose for covid-19 immunization. Vaccination Facility was Physician Office Hospital. Medical history included diabetes for which patient takes unspecified high blood pressure medication. Concomitant medication was Januvia for diabetes. On 23Feb2021 the patient experienced itching at injection site, swelling at injection site, injection site warm to touch. It was reported should he seek further treatment or advice. The adverse events does not require physician office visit and emergency room visit. The patient did not receive any other vaccines within 4 weeks prior to the covid-19 vaccine. Patient was not administered any vaccine on same date of the suspect. Outcome of reaction/event at the time of last observation was not recovered/not resolved.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Fatigue; This is a spontaneous report from a contactable consumer (patient). A 46-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6202) via an unspecified route of administration on 22Feb2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 23Feb2021, the patient experienced fatigue. He said that the fatigue is mild. Outcome of the event was unknown.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes simplex
Clinical narrative: Herpes simplex; This is a spontaneous report from a contactable other health professional (reported for herself). A 54-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 22Feb2021 16:00 (Batch/Lot number was not reported) at the age of 54 years old as single dose for covid-19 immunisation. Medical history included Encephalitis Herpes simplex; No Known allergies. Concomitant medications in two weeks included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL); vitamins nos (MULTIVITAMIN [VITAMINS NOS]). Facility type vaccine other Public housing. No other vaccine in four weeks. The patient experienced Herpes simplex on 27Feb2021 07:00. No Treatment Received. No covid prior vaccination and no covid tested post vaccination. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough
Clinical narrative: This is a spontaneous report received from a Pfizer-sponsored program. A female patient (reported herself) of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: Expiry date: Unknown), via an unspecified route of administration on 18Feb2021 at SINGLE DOSE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced cough tickling on her throat. The treatment included Benzonatate 100mg yesterday wants to know if that is safe given that she had 1st dose. The outcome of the event was Unknown. Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Cough, Dizziness, Headache, Muscle spasms
Clinical narrative: This is a spontaneous report received from a Pfizer-sponsored program. A female patient (reported herself) of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: Expiry date: Unknown), via an unspecified route of administration on 18Feb2021 at SINGLE DOSE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced cough tickling on her throat. The treatment included Benzonatate 100mg yesterday wants to know if that is safe given that she had 1st dose. The outcome of the event was Unknown. Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Regurgitation, Throat irritation
Clinical narrative: This is a spontaneous report received from a Pfizer-sponsored program. A female patient (reported herself) of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: Expiry date: Unknown), via an unspecified route of administration on 18Feb2021 at SINGLE DOSE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced cough tickling on her throat. The treatment included Benzonatate 100mg yesterday wants to know if that is safe given that she had 1st dose. The outcome of the event was Unknown. Information on the lot/batch number has been requested.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, SARS-CoV-2 test
Clinical narrative: whenever patient felt good and did few things but experience a relapse pretty quickly; fever was close to 103; This is a spontaneous report received from a contactable consumer (patient). A 71-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9267) via unspecified route of administration in right arm on 18Feb2021 at 11:00, (at the age of 71-year-old) as a single dose for COVID-19 immunization. The patient medical history included heart and diabetes mellitus II. The patient had no known allergies. The patient was taking medication (unspecified) within two weeks of vaccination. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19 (nasal swab) on 27Feb2021 and resulted in negative. About 4 days after vaccination that was on 22Feb2021, started having mild symptoms. On 25Feb2021, the patient had fever was close to 103. Since that time patient temperature has bounced all over the place and was 102.5 this morning (on an unknown date in 2021). It was reported that whenever patient felt good and did few things but experience a relapse pretty quickly. The patient was scheduled for the second shot on 11Mar2021, and the patient was not sure what to do. The patient did not receive any treatment for the events. The outcome of the events was not recovered.
Sex: F
Vaccine: PPV
Symptoms: No adverse event
Clinical narrative: States did not react to pneumonia vaccine and verbalizes it does not itch. Was monitored thirty minutes post administration; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received pneumococcal 13-val conj vac (dipht crm197 protein) via an unspecified route of administration on an unspecified date as an unspecified dose for immunisation. The patient medical history and concomitant medications were not reported. On an unknown date, it was reported that did not react to pneumonia vaccine and verbalizes it does not itch. was monitored thirty minutes post administration. The outcome of the event was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis
Clinical narrative: Sweating; This is a spontaneous report from a contactable consumer (patient mother). A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: Unknown) via an unspecified route of administration on 05Feb2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient was sweating for 2 days. Outcome for the event was unknown.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: She was able to speak a lot of clearer words after both covid shot; This is a spontaneous report from a contactable consumer (patient's son). A 90-Year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number: unknown) via unspecified route on an unknown date at single dose for COVID-19 immunization. The patient's relevant medical history included Broca's Aphasia. Concomitant medication was not reported. It was reported that the 90-year-old patient who has Broca's Aphasia received her 2 shots. The patient was able to speak a lot of clearer words after both COVID shots. It was reported that this was extremely interesting, and they thought they would share the info. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, Exposure to SARS-CoV-2, Nasopharyngitis, Pain in extremity
Clinical narrative: tested positive for covid 19; tested positive for covid 19; exposed to someone with covid virus; started feeling a head cold; arm a little sore; This is a spontaneous report from Pfizer-sponsored program. A contactable consumer reported for herself that a 65-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expatriation date was not reported), via an unspecified route of administration on 20Feb2021, dose 1 via an unspecified route of administration (Batch/Lot number was not reported) on 30Jan2021, both as single dose for covid-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD). The patient's concomitant medications were not reported. Patient was exposed to someone with covid virus that weekend following the second dose on Feb2021. patient tested on Wednesday, tested negative, then patient started feeling a head cold, and patient re-tested on 26Feb2021 and tested positive for covid 19 which landed her in the ER. Patient has COPD and the ER HCP felt she needed to have infusion of monoclonal infusion. patient read that if one receives this infusion, they should wait 3 months for the vaccine. Since she had this done after the vaccine, she is asking how this will affect the effectiveness of covax and should she redo the vaccine. Patient states that she had no adverse reactions from both doses though, each vaccine made her arm a little sore. Therapeutic measures were taken as a result of tested positive for covid 19. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: tested positive for covid 19; tested positive for covid 19; exposed to someone with covid virus; started feeling a head cold; arm a little sore; This is a spontaneous report from Pfizer-sponsored program. A contactable consumer reported for herself that a 65-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expatriation date was not reported), via an unspecified route of administration on 20Feb2021, dose 1 via an unspecified route of administration (Batch/Lot number was not reported) on 30Jan2021, both as single dose for covid-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD). The patient's concomitant medications were not reported. Patient was exposed to someone with covid virus that weekend following the second dose on Feb2021. patient tested on Wednesday, tested negative, then patient started feeling a head cold, and patient re-tested on 26Feb2021 and tested positive for covid 19 which landed her in the ER. Patient has COPD and the ER HCP felt she needed to have infusion of monoclonal infusion. patient read that if one receives this infusion, they should wait 3 months for the vaccine. Since she had this done after the vaccine, she is asking how this will affect the effectiveness of covax and should she redo the vaccine. Patient states that she had no adverse reactions from both doses though, each vaccine made her arm a little sore. Therapeutic measures were taken as a result of tested positive for covid 19. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: covid test result=Positive; covid test result=Positive; This is a spontaneous report from a contactable consumer (patient). A 54-year-old male patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN5318), via an unspecified route of administration in left arm on 26Jan2021 as single dose for Covid-19 immunisation. Medical history included none. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. Prior to vaccination, the patient was not diagnosed with Covid-19. Post vaccination, the patient had been tested for Covid-19. The patient underwent lab tests and procedures which included sars-cov-2 test (Covid test type: nasal swab) positive. There was no treatment received for the adverse events. The outcome of the events was unknown.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion
Clinical narrative: Congestion; This is a spontaneous report from a non-contactable consumer (patient). A 40-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 26Feb2021 17:30 (Lot Number: 18) at the age of 40 years old as single dose for covid-19 immunisation. The patient's medical history included No known allergies. Concomitant medications were not reported. Facility type vaccine was Pharmacy or Drug store. No other vaccine in four weeks. The patient experienced congestion on 27Feb2021 06:00. No treatment received. No covid prior vaccination and no covid tested post vaccination. The outcome of the event was recovering.    No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Diarrhoea, Drug ineffective, Nausea, Oropharyngeal pain
Clinical narrative: COVID test on 13Jan21 resulted as positive; COVID test on 13Jan21 resulted as positive; Symptoms of sore throat, Nausea/Vomiting/ Diarrhea; Symptoms of sore throat, Nausea/Vomiting/ Diarrhea; Symptoms of sore throat, Nausea/Vomiting/ Diarrhea; Symptoms of sore throat, Nausea/Vomiting/ Diarrhea; This is a spontaneous report from a contactable pharmacist. A 34-years-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number was EL1284 and expiration date was not reported; 34 year age at time of vaccination), dose 1 intramuscular, administered in arm left on 23Dec2020 at 13:30 as single dose for covid-19 immunisation. The patient medical history included tested COVID+ on 13Nov2020 following household exposure. Concomitant medications included salbutamol (albuterol) at unknown dose at every 4 hrs (q4h prn) for sob (shortness of breath)/wheezing, citalopram and clonazepam. The patient known allergies included sulfadiazine (hives) and bananas (throat swelling). The patient previously had allergy to sulfadiazine (hives), bananas (throat swelling). other medications in two weeks: albuterol mdi q4h prn sob/wheezing, citalopram (unknown dose), clonazepam (unknown dose). Received first COVID vaccine 23Dec2020. Symptoms of sore throat, Nausea/Vomiting/ Diarrhea started on 12Jan21 08:00 prior to receiving her 2nd vaccine dose. COVID test on 13Jan21 resulted as positive. Patient not received treatment. Patient had covid prior vaccination (COVID+ on 13Nov2020 following household exposure); patient was covid tested post vaccination; covid test post vaccination covid test type post vaccination=Nasal Swab; covid test date=13Jan2021; covid test result=Positive. The outcome of the events was resolved in 2021.; Sender's Comments: Considering a plausible temporal relationship and known product safety profile, a possible contributory role of suspect product Comirnaty to the reported 'COVID 19' cannot be completely excluded.
Age: 34.0
Sex: U
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: COVID test on 13Jan21 resulted as positive; COVID test on 13Jan21 resulted as positive; Symptoms of sore throat, Nausea/Vomiting/ Diarrhea; Symptoms of sore throat, Nausea/Vomiting/ Diarrhea; Symptoms of sore throat, Nausea/Vomiting/ Diarrhea; Symptoms of sore throat, Nausea/Vomiting/ Diarrhea; This is a spontaneous report from a contactable pharmacist. A 34-years-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number was EL1284 and expiration date was not reported; 34 year age at time of vaccination), dose 1 intramuscular, administered in arm left on 23Dec2020 at 13:30 as single dose for covid-19 immunisation. The patient medical history included tested COVID+ on 13Nov2020 following household exposure. Concomitant medications included salbutamol (albuterol) at unknown dose at every 4 hrs (q4h prn) for sob (shortness of breath)/wheezing, citalopram and clonazepam. The patient known allergies included sulfadiazine (hives) and bananas (throat swelling). The patient previously had allergy to sulfadiazine (hives), bananas (throat swelling). other medications in two weeks: albuterol mdi q4h prn sob/wheezing, citalopram (unknown dose), clonazepam (unknown dose). Received first COVID vaccine 23Dec2020. Symptoms of sore throat, Nausea/Vomiting/ Diarrhea started on 12Jan21 08:00 prior to receiving her 2nd vaccine dose. COVID test on 13Jan21 resulted as positive. Patient not received treatment. Patient had covid prior vaccination (COVID+ on 13Nov2020 following household exposure); patient was covid tested post vaccination; covid test post vaccination covid test type post vaccination=Nasal Swab; covid test date=13Jan2021; covid test result=Positive. The outcome of the events was resolved in 2021.; Sender's Comments: Considering a plausible temporal relationship and known product safety profile, a possible contributory role of suspect product Comirnaty to the reported 'COVID 19' cannot be completely excluded.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Headache; fatigue; This is a spontaneous report from a contactable nurse (patient). A 72-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6202), second dose via an unspecified route of administration, administered in right arm on 25Feb2021 13:45 as SINGLE DOSE for covid-19 immunization. Patient was 72 years old at the time of vaccination. Medical history included chronic obstructive pulmonary disease, hypothyroidism and arthritis. Patient did not tested positive for Covid prior to vaccination. Patient had no known allergies. Patient did not receive any other vaccine in 4 weeks prior to vaccination. On 04Feb2021 at 8:30 patient received first dose of bnt162b2(lot number: EL3249) in right arm. Concomitant medications included BUDESONIDE, levothyroxine sodium (SYNTHROID), NABUMETONE, formoterol fumarate (PERFOROMIST), revefenacin (YUPELRI), all taken on unspecified date for unknown indication. On 26Feb2021 at 06:00 the patient experienced headache and fatigue. Outcome of the events was recovering.  No follow up attempts are possible. No further information is expected.